iReach2: Internet Obesity Treatment Enhanced With Motivational Interviewing

Sponsor
University of Vermont (Other)
Overall Status
Completed
CT.gov ID
NCT01232699
Collaborator
University of Arkansas (Other)
495
2
3
40
247.5
6.2

Study Details

Study Description

Brief Summary

Internet-based weight control programs have been shown effective in producing weight loss, but in-person delivery of behavioral weight control produces significantly greater weight loss than on-line delivery of the same program. Motivational Interviewing has been shown to increase weight loss when delivered as an adjunct to in-person weight loss programs but has not been examined in conjunction with web-based obesity treatment. Therefore, the overall goal of this project is to determine if the addition of on-line Motivational Interviewing to a web-based group behavioral obesity treatment program will augment weight loss outcomes.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Internet Obesity Treatment
  • Behavioral: Internet Obesity Treatment with MI
  • Behavioral: Contingent MI
N/A

Detailed Description

This randomized controlled trial is designed to determine whether weight losses in a group behavioral weight loss intervention conducted over the Internet are increased with the inclusion of individual, online MI sessions. All participants will receive the same online 6-month group-based behavioral weight loss program followed by 12 months of weight maintenance. Overweight and obese adults at two study sties (N=426) will be randomized to (1) Internet intervention; or 2) Internet intervention with individual MI sessions occurring at three month intervals on a fixed schedule (Internet+MI-Fixed). Assessments will be conducted every six months and will include measures of body weight and height, diet and exercise behaviors, Quality of Life, adherence measures (eg., attendance, compliance with self-monitoring), social influence components, motivation, treatment satisfaction, demographic data and descriptive information regarding use of website components. A third arm was added for the final 3 intervention cohorts. All participants received the program as described above with the addition of motivational interviewing contingent on participants' attendance in classes.

Study Design

Study Type:
Interventional
Actual Enrollment :
495 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Internet Obesity Treatment Enhanced With Motivational Interviewing
Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Apr 1, 2014
Actual Study Completion Date :
Apr 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Internet Obesity Treatment

Participants will attend weekly class sessions on line and track food and exercise in an on-line journal.

Behavioral: Internet Obesity Treatment
Participants will engage in self monitoring, will receive skills training to help cope with environmental triggers, and will receive nutrition advice.
Other Names:
  • iREACH2
  • Experimental: Internet Obesity Treatment with MI

    Participants will attend weekly classes on line, record food and exercise in an on-line journal, and will have no more than 6 individual motivational interviewing sessions.

    Behavioral: Internet Obesity Treatment with MI
    In addition to weekly group meetings, self-monitoring through recording calorie and fat intake daily as well as exercise, participants will meet one-on-one with an MI counselor on-line in order to augment an individual's motivation to change behavior.
    Other Names:
  • iREACH2
  • Experimental: Contingent MI

    Intervention is the same as for the MI arm, however participants will only receive MI if meeting certain treatment participation conditions.

    Behavioral: Contingent MI
    Participants will attend weekly behavioral internet meetings. They may or may not receive Motivational Interviewing depending on their class attendance.
    Other Names:
  • iReach2
  • Outcome Measures

    Primary Outcome Measures

    1. Change in Body Weight [6 months]

      Weights will be taken in street clothes without shoes using a hospital quality digital floor model scale.

    2. Change in Body Weight [12 months]

    3. Change in Body Weight [18 months]

    4. Change in body weight [0]

      Weights will be taken in street clothes without shoes using a hospital quality digital floor model scale. Height will be taken at baseline using a wall-mounted stadiometer and BMI will be calculated as weight (kg)/height(m2)

    Secondary Outcome Measures

    1. Adherence to Treatment Components [6 months]

      Items will include attendance at chat group meetings and completion of online food diaries and exercise records.

    2. Adherence to Treatment Components [12 months]

    3. Adherence to Treatment Components [18 months]

    4. Motivation Measures [0]

      We will assess participant motivation for participating in a weight reduction program and adhering to the program.

    5. Motivation Measures [6]

    6. Motivation Measures [12 months]

    7. Motivation Measures [18 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • must be over 18

    • must have a BMI between 18 and 50

    • must live within 60 minutes driving distance of University of Arkansas, Little Rock, AR, or University of Vermont, Burlington, Vermont

    • must be able to walk for exercise

    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Arkansas for the Medical Sciences Little Rock Arkansas United States 72205
    2 Behavioral Weight Management Program/Univ of Vermont Burlington Vermont United States 05405

    Sponsors and Collaborators

    • University of Vermont
    • University of Arkansas

    Investigators

    • Principal Investigator: Jean R Harvey Berino, PhD., University of Vermont
    • Principal Investigator: Delia Smith-West, PhD., UAMS

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jean R. Harvey, PhD, RD, Principal Investigator, University of Vermont
    ClinicalTrials.gov Identifier:
    NCT01232699
    Other Study ID Numbers:
    • 10-124
    First Posted:
    Nov 2, 2010
    Last Update Posted:
    Dec 24, 2018
    Last Verified:
    Dec 1, 2018
    Keywords provided by Jean R. Harvey, PhD, RD, Principal Investigator, University of Vermont
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 24, 2018